These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11805286)

  • 21. Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription.
    Becherel OJ; Gueven N; Birrell GW; Schreiber V; Suraweera A; Jakob B; Taucher-Scholz G; Lavin MF
    Hum Mol Genet; 2006 Jul; 15(14):2239-49. PubMed ID: 16777843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
    Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
    Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PolyADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation.
    Smith HM; Grosovsky AJ
    Carcinogenesis; 1999 Aug; 20(8):1439-43. PubMed ID: 10426789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of topoisomerases in mammospheres derived from breast cancer cell line: clinical implications for combined treatments with tyrosine kinase inhibitors.
    Peleg R; Romzova M; Kogan-Zviagin I; Apte RN; Priel E
    BMC Cancer; 2014 Dec; 14():910. PubMed ID: 25472619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human topoisomerase I C-terminal domain fragment containing the active site tyrosine is a molten globule: implication for the formation of competent productive complex.
    Punchihewa C; Dai J; Carver M; Yang D
    J Struct Biol; 2007 Jul; 159(1):111-21. PubMed ID: 17434318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.
    Gobert C; Skladanowski A; Larsen AK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10355-60. PubMed ID: 10468612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
    Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
    Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
    Coleman LW; Bronstein IB; Holden JA
    Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions.
    Shaiu WL; Hu T; Hsieh TS
    Pac Symp Biocomput; 1999; ():578-89. PubMed ID: 10380229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
    Mo YY; Beck WT
    Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
    Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
    Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in mobility account for camptothecin-induced subnuclear relocation of topoisomerase I.
    Christensen MO; Barthelmes HU; Feineis S; Knudsen BR; Andersen AH; Boege F; Mielke C
    J Biol Chem; 2002 May; 277(18):15661-5. PubMed ID: 11907023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
    Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raman and CD spectroscopy of recombinant 68-kDa DNA human topoisomerase I and its complex with suicide DNA-substrate.
    Fleury F; Ianoul A; Kryukov E; Sukhanova A; Kudelina I; Wynne-Jones A; Bronstein IB; Maizieres M; Berjot M; Dodson GG; Wilkinson AJ; Holden JA; Feofanov AV; Alix AJ; Jardillier JC; Nabiev I
    Biochemistry; 1998 Oct; 37(41):14630-42. PubMed ID: 9772192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.
    Christensen MO; Barthelmes HU; Boege F; Mielke C
    Nucleic Acids Res; 2003 Dec; 31(24):7255-63. PubMed ID: 14654701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes.
    Govoni M; Neri S; Labella T; Sylvester JE; Novello F; Pession A
    Biochem Biophys Res Commun; 1995 Aug; 213(1):282-8. PubMed ID: 7639746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SR protein B52/SRp55 is required for DNA topoisomerase I recruitment to chromatin, mRNA release and transcription shutdown.
    Juge F; Fernando C; Fic W; Tazi J
    PLoS Genet; 2010 Sep; 6(9):e1001124. PubMed ID: 20862310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants.
    Albor A; Kaku S; Kulesz-Martin M
    Cancer Res; 1998 May; 58(10):2091-4. PubMed ID: 9605749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of human topoisomerase I by fragment complementation.
    Stewart L; Ireton GC; Champoux JJ
    J Mol Biol; 1997 Jun; 269(3):355-72. PubMed ID: 9199405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein.
    Mo YY; Yu Y; Shen Z; Beck WT
    J Biol Chem; 2002 Jan; 277(4):2958-64. PubMed ID: 11709553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.